Skip to content

Efficacy of Flow Restrictors in Limiting Access of Liquid Medicines by Young Children

Efficacy of Flow Restrictors in Limiting Access of Liquid Medicines by Young Children

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06938620
Enrollment
120
Registered
2025-04-22
Start date
2012-04-30
Completion date
2012-05-31
Last updated
2025-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Enhanced Child-safety Packaging

Keywords

Child Injury, Child-resistant Packaging, Pediatric Poisoning, Medication Safety, Injury Prevention

Brief summary

This study aimed to assess whether adding flow restrictors, adapters added to the neck of a bottle to limit the release of liquid, affects the proportion of preschool-aged children who can access liquid bottle contents, the amount accessed, and the time required for children to empty the bottles compared with traditional bottles without flow restrictors.

Detailed description

Unsupervised ingestion of medications by young children is an important public health concern, leading to tens of thousands of emergency department visits and many more calls to poison control centers each year. Current knowledge on the specific circumstances in which young children gain access to medications is limited; however, a number of studies have shown that improper replacement of child-resistant packaging (CRP) by a caregiver leads to a substantial number of these incidents. Beginning in 2011, several pharmaceutical manufacturers introduced flow restrictors on over-the-counter (OTC) infants' acetaminophen; however, the efficacy of flow restrictors in limiting accessibility of liquid medicines by young children has not been formally assessed. This study sought to determine whether adding flow restrictors, adapters added to the neck of a bottle to limit the release of liquid, to liquid medicine bottles can provide additional protection against unsupervised medicine ingestions by young children. A modified version of the standard child test protocol for re-closeable packages outlined in the Poison Prevention Packaging Act (PPPA protocol) was used to assess the efficacy of flow restrictors in limiting children's access to liquid medicines. Preschool-aged children participated in two 10-minute trials in which they were asked to try to get everything out of bottles filled with test liquid (a food product with similar flow characteristics to liquid medicine). Randomized block design was used to assign specific bottles to participants. Each child tested an uncapped bottle with a flow restrictor (FR-bottle) for one trial (1 of 3 designs randomly assigned). For the other trial, the child tested a control bottle (a traditional bottle either no cap or an incompletely-closed child-resistant cap). The amount of liquid the child removed from each bottle was measured and the time required to empty bottles was recorded. If flow restrictors limit the amount of liquid a young child can access, even when the outer child-resistant cap is not fully secured, their use could potentially be expanded to other liquid medicines.

Interventions

OTHERBottle with a flow restrictor

Flow restrictors added to liquid medicine bottles to determine whether they limit accessibility of liquid bottle contents to young children compared with control bottles without flow restrictors.

OTHERControl bottle

Traditional bottle either no cap or an incompletely-closed child-resistant cap

Sponsors

Grady Health System
CollaboratorOTHER
Emory University
CollaboratorOTHER
Centers for Disease Control and Prevention
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
36 Months to 59 Months
Healthy volunteers
Yes

Inclusion criteria

* Attends one of the participating preschools * Is between 36 - 59 months of age * Is an English speaker

Exclusion criteria

* Has an obvious or overt, temporary or permanent, injury, illness, or physical or mental disability * Has known allergies/restrictions to ingesting any ingredients in the test liquid

Design outcomes

Primary

MeasureTime frameDescription
Proportion of children who removed specified amounts of test liquid from FR-bottles compared with control bottles0 daysProportion of children who emptied bottles, removed ≥ 25 mL, and who removed ≥ 5 mL of liquid from FR-bottles compared with control bottles

Secondary

MeasureTime frameDescription
Time required to empty the bottles0 daysProportion of children who emptied bottles, removed ≥ 25 mL, and who removed ≥ 5 mL of liquid from FR-bottles compared with control bottles
Proportion of liquid removed from bottles0 daysProportion of children who emptied bottles, removed ≥ 25 mL, and who removed ≥ 5 mL of liquid from FR-bottles compared with control bottles
Approaches used to remove liquid from bottles0 daysProportion of children who emptied bottles, removed ≥ 25 mL, and who removed ≥ 5 mL of liquid from FR-bottles compared with control bottles
Differences in proportions of children who removed specified amounts of liquid by age, sex, and site0 daysProportion of children who emptied bottles, removed ≥ 25 mL, and who removed ≥ 5 mL of liquid from FR-bottles compared with control bottles

Other

MeasureTime frameDescription
Amount of test liquid removed from individual FR-bottle designs0 daysProportion of children who emptied bottles, removed ≥ 25 mL, and who removed ≥ 5 mL of liquid from FR-bottles compared with control bottles

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026